GLPwatch
Trials (2167)
Page 31 of 37.
- A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
- A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
- Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
- Incretin-based Drugs and Pancreatic Cancer
- Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
- Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
- COMMETS- Combination MCI Metabolic Syndrome
- A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
- Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
- Semaglutide for Post-Smoking Cessation Weight Management
- A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
- HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
- Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
- Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
- Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
- Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
- The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
- Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
- The Effect of Weekly Semaglutide Treatment on Energy Expenditure
- A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
- Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
- A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
- Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
- A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
- Role of Exenatide in Type 1 Diabetes
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
- Semaglutide to Reduce Atrial Fibrillation Burden
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
- Semaglutide for Smoking Cessation in Patients With Diabetes
- The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
- Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
- Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
- Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
- A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
- Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
- Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
- The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
- A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
- Individualized Obesity Pharmacotherapy
- DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
- A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
- GLP1-imaging Before and After Bariatric Surgery
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
- Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- Study of Patients Being Treated With Anti-obesity Medication
- Reward Mechanisms in Obesity